Managing diabetes and hypertension in chronic kidney disease. Issue 11 (November 2021)

• Record Type: Journal Article
• Authors: Mead, Daniel; Dinh, Nhan; Wentworth, Danielle; Thomas, Sofia; Suthar, Meera
• Is Part Of: Nurse practitioner. Volume 46:Issue 11(2021)
• Publication Date: 2021-11
• Subjects: chronic kidney disease -- diabetes -- diabetic kidney disease -- glomerular filtration rate -- hypertension -- NKF-ASN task force -- race and eGFR -- SGLT2 inhibitors; Nursing -- Periodicals; Nurse practitioners -- Periodicals; 610.73
• DOI: 10.1097/01.NPR.0000794508.22673.f2
• Languages: English
• ISSNs: 0361-1817

Abstract

Abstract : Abstract: Since 2020, several guidelines have been published to help health practitioners better manage hypertension and diabetes in patients with chronic kidney disease. Scrutiny on the inclusion of race in determining the estimated glomerular filtration rate (eGFR) as well as breakthrough research regarding the drug dapagliflozin for the treatment of patients with chronic kidney disease are discussed. Abstract : Since 2020, several guidelines have been published to help health practitioners better manage hypertension and diabetes in patients with chronic kidney disease. Scrutiny on the inclusion of race in determining the estimated glomerular filtration rate (eGFR) as well as breakthrough research regarding the drug dapagliflozin for the treatment of patients with chronic kidney disease are discussed.